Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 18.38B | 19.85B | 21.66B | 18.26B | 14.78B |
Gross Profit | 14.23B | 14.55B | 13.04B | 12.16B | 12.40B |
EBITDA | 7.63B | 6.83B | 6.91B | 6.27B | 3.89B |
Net Income | 2.90B | 2.29B | 7.80B | 2.35B | 1.64B |
Balance Sheet | |||||
Total Assets | 106.74B | 98.33B | 92.70B | 94.86B | 67.22B |
Cash, Cash Equivalents and Short-Term Investments | 6.93B | 4.25B | 2.77B | 3.35B | 2.50B |
Total Debt | 48.36B | 47.07B | 42.98B | 45.47B | 31.22B |
Total Liabilities | 68.92B | 68.43B | 63.13B | 71.00B | 47.36B |
Stockholders Equity | 37.80B | 29.87B | 29.54B | 23.83B | 19.84B |
Cash Flow | |||||
Free Cash Flow | -2.50B | -514.00M | 6.00M | 728.00M | -327.00M |
Operating Cash Flow | 6.81B | 6.94B | 6.90B | 6.27B | 4.46B |
Investing Cash Flow | -10.57B | -7.50B | 240.00M | -14.01B | -5.12B |
Financing Cash Flow | 4.53B | 987.00M | -7.17B | 7.77B | 750.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | £50.56B | 16.73 | 8.35% | 5.99% | -7.42% | 5.84% | |
71 Outperform | £8.05B | 34.97 | 12.73% | 3.98% | 5.38% | 86.34% | |
71 Outperform | £19.97B | 16.78 | 12.29% | 2.33% | -13.09% | 231.40% | |
68 Neutral | £7.59B | 6.17 | 32.10% | 3.79% | -24.74% | -63.34% | |
64 Neutral | €7.52B | 4.14 | -0.91% | 4.51% | 7.45% | -19.93% | |
£154.09M | 1.28 | 5.84% | ― | ― | |||
64 Neutral | £7.64B | 28.85 | 13.05% | 4.50% | 8.61% | ― |